Impaired Kidney Function and Atrial Fibrillation in Elderly Subjects

Go, 2001, Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study, JAMA, 285, 2370, 10.1001/jama.285.18.2370 Coresh, 2004, Evidence for increased cardiovascular disease risk in patients with chronic kidney disease, Curr Opin Nephrol Hypertens, 13, 73, 10.1097/00041552-200401000-00011 Weiner, 2004, Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies, J Am Soc Nephrol, 15, 1307, 10.1097/01.ASN.0000123691.46138.E2 Go, 2004, Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization, N Engl J Med, 351, 1296, 10.1056/NEJMoa041031 Shlipak, 2005, Cystatin-C and mortality in elderly persons with heart failure, J Am Coll Cardiol, 45, 268, 10.1016/j.jacc.2004.09.061 Shlipak, 2005, Cystatin C and the risk of death and cardiovascular events among elderly persons, N Engl J Med, 352, 2049, 10.1056/NEJMoa043161 Schrier, 1990, Body fluid volume regulation in health and disease: a unifying hypothesis, Ann Intern Med, 113, 155, 10.7326/0003-4819-113-2-155 Zucker, 1985, Imparied atrial receptor modulation or renal nerve activity in dogs with chronic volume overload, Cardiovasc Res, 19, 411, 10.1093/cvr/19.7.411 Madrid, 2002, Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study, Circulation, 106, 331, 10.1161/01.CIR.0000022665.18619.83 Pedersen, 1999, Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction, Circulation, 100, 376, 10.1161/01.CIR.100.4.376 Van Den Berg, 1995, Effects of lisinopril in patients with heart failure and chronic atrial fibrillation, J Card Fail, 1, 355, 10.1016/S1071-9164(05)80004-1 Vermes, 2003, Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials, Circulation, 107, 2926, 10.1161/01.CIR.0000072793.81076.D4 Wachtell, 2005, Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study, J Am Coll Cardiol, 45, 712, 10.1016/j.jacc.2004.10.068 Ueng, 2003, Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation. Results of a prospective and controlled study, Eur Heart J, 24, 2090, 10.1016/j.ehj.2003.08.014 Nakashima, 2000, Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation, Circulation, 101, 2612, 10.1161/01.CIR.101.22.2612 Unger, 2002, The role of the renin-angiotensin system in the development of cardiovascular disease, Am J Cardiol, 89, 3A, 10.1016/S0002-9149(01)02321-9 Rocha, 2001, Pathophysiological effects of aldosterone in cardiovascular tissues, Trends Endocrinol Metab, 12, 308, 10.1016/S1043-2760(01)00432-5 Weber, 1991, Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system, Circulation, 83, 1849, 10.1161/01.CIR.83.6.1849 Delcayre, 2000, Cardiac aldosterone production and ventricular remodeling, Kidney Int, 57, 1346, 10.1046/j.1523-1755.2000.00973.x Novo, 1987, Changes of angiotensin converting enzyme (ACE) levels during activation of the renin-angiotensin-aldosterone system (RAAs), Agents Actions Suppl, 22, 339 Remuzzi, 2005, The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease, Kidney Int Suppl, 99, S57, 10.1111/j.1523-1755.2005.09911.x Boldt, 2006, ACE-inhibitor treatment attenuates atrial structural remodeling in patients with lone chronic atrial fibrillation, Basic Res Cardiol, 10, 261, 10.1007/s00395-005-0571-2 Fried, 1991, The Cardiovascular Health Study: design and rationale, Ann Epidemiol, 1, 263, 10.1016/1047-2797(91)90005-W Cushman, 1995, Laboratory methods and quality assurance in the Cardiovascular Health Study, Clin Chem, 41, 264, 10.1093/clinchem/41.2.264 Furberg, 1994, Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study), Am J Cardiol, 74, 236, 10.1016/0002-9149(94)90363-8 Rautaharju, 1990, Methodology of ECG interpretation in the Dalhousie program; NOVACODE ECG classification procedures for clinical trials and population health surveys, Methods Inf Med, 29, 362, 10.1055/s-0038-1634798 Psaty, 1997, Incidence of and risk factors for atrial fibrillation in older adults, Circulation, 96, 2455, 10.1161/01.CIR.96.7.2455 Erlandsen, 1999, Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II System, Scand J Clin Lab Invest, 59, 1, 10.1080/00365519950185940 Levey, 1999, A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group, Ann Intern Med, 130, 461, 10.7326/0003-4819-130-6-199903160-00002 Shlipak, 2005, Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors, JAMA, 293, 1737, 10.1001/jama.293.14.1737 Levey, 2003, National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification, Ann Intern Med, 139, 137, 10.7326/0003-4819-139-2-200307150-00013 Aviles, 2003, Inflammation as a risk factor for atrial fibrillation, Circulation, 108, 3006, 10.1161/01.CIR.0000103131.70301.4F Shi, 2002, Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure, Cardiovasc Res, 54, 456, 10.1016/S0008-6363(02)00243-2 Ravelli, 1997, Effects of atrial dilatation on refractory period and vulnerability to atrial fibrillation in the isolated Langendorff-perfused rabbit heart, Circulation, 96, 1686, 10.1161/01.CIR.96.5.1686 Wijffels, 1995, Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats, Circulation, 92, 1954, 10.1161/01.CIR.92.7.1954 Shi, 2001, Remodeling of atrial dimensions and emptying function in canine models of atrial fibrillation, Cardiovasc Res, 52, 217, 10.1016/S0008-6363(01)00377-7 Knight, 2004, Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement, Kidney Int, 65, 1416, 10.1111/j.1523-1755.2004.00517.x